Efficacy and speed of kill of a topically applied formulation of dinotefuran-permethrin-pyriproxyfen against weekly tick infestations with  () on dogs by unknown
RESEARCH Open Access
Efficacy and speed of kill of a topically
applied formulation of dinotefuran-
permethrin-pyriproxyfen against weekly
tick infestations with Rhipicephalus
sanguineus (sensu lato) on dogs
Jeffrey Blair1, Josephus J. Fourie2, Marie Varloud1* and Ivan G. Horak2,3
Abstract
Background: Rhipicephalus sanguineus (sensu lato) is a vector of canine babesiosis, anaplasmosis and ehrlichiosis.
In order to reduce the chance of transmission of these diseases, an ectoparasiticide should rapidly repel or kill new
infestations with this tick. The primary objective of the present study was to evaluate the treatment and preventive
acaricidal efficacy of Vectra® 3D (54.45 mg/ml of dinotefuran, 396.88 mg/ml of permethrin and 4.84 mg/ml of
pyriproxyfen) against R. sanguineus (s.l.) measured at 2, 8, and 48 h after treatment and weekly re-infestation.
Methods: Twenty-four dogs were each infested with 50 adult R. sanguineus (s.l.) on Day -7 and allocated to three
groups (n = 8) based on tick counts: an untreated control group (Group 1), and two groups (Groups 2 and 3) treated
with Vectra®3D. The dogs in each group were infested with 50 ticks on Day -2. Vectra®3D was administered topically
to the dogs on Day 0. Ticks were counted, in situ at 2 and 8 h after treatment on dogs in Groups 1 and 3. Group 3 was
then withdrawn from the study and ticks were counted and removed from the dogs in Groups 1 and 2, 48 h after
treatment. On Days 7, 14, 21, 28, 35 and 42, the dogs in Groups 1 and 2 were re-infested with 50 ticks, which were
then counted in situ at 2 and 8 h, and counted and removed at 48 h after re-infestation.
Results: Ticks from the initial infestation were visually unaffected by 2 and 8 h after treatment. However, by 2 h after
weekly re-infestation the arithmetic mean (AM) efficacy of Vectra® 3D from Days 7 through 28 ranged from 61.1 to 78.8 %,
falling to 60.1 and 47.4 % on Days 35 and 42 respectively. By 8 h after weekly re-infestation, the AM efficacy ranged from
89.1 to 97.4 % falling to 81.4 and 69.8 % on Days 35 and 42 respectively. The AM efficacy 48 h after treatment after the
initial infestation was 22.9 % but after weekly re-infestation the efficacy at 48 h ranged from 89.1 to 100.0 %, falling to 86.0
and 81.1 % on Days 35 and 42 respectively.
Conclusion: Vectra® 3D demonstrated significant efficacy against new infestations of adult R. sanguineus (s.l.) ticks within
2 h of infestation as compared to the untreated control group and achieved over 89.1 % efficacy within 8 h of infestation
for up to 4 weeks after administration. These results indicate that Vectra® 3D has a rapid and significant efficacy against
new infestations of adult R. sanguineus (s.l.) ticks and should therefore be considered as part of a strategy against
important vector-borne diseases in dogs.
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Background
The topical formulation (Vectra® 3D, DPP) used in this
study is a combination of 54.45 mg/ml of dinotefuran,
396.88 mg/ml of permethrin and 4.84 mg/ml of pyri-
proxyfen with a broad spectrum of activity against exter-
nal parasites of dogs. Permethrin, the primary acaricidal
component of this formulation, is a photostable syn-
thetic pyrethroid with a relatively long residual activity
that prevents the closure of the sodium channels, leaving
the nerve cell membrane in a permanent state of
depolarization [1]. It is this mode of action that results
in the sudden “knock down” effect on pests and espe-
cially the “hot foot” reaction of ticks coming in con-
tact with treated dogs. Moreover, permethrin is also
an arthropod repellent [2]. Dinotefuran is a fast-acting
insecticide furanicotinyl belonging to the most recent
generation of neonicotinoid [3] and pyriproxyfen is an
insect growth regulator that targets and disrupts the
reproductive and endocrine systems of insects [4].
Rhipicephalus sanguineus (sensu lato) is a three-host
tick species, and with few exceptions its larvae,
nymphs and adults feed almost exclusively on domes-
tic dogs [5–8]. It is the most widespread tick in the
world [6]. Female ticks may deposit eggs under a dog’s
bedding or in nearby sheltered spots, or they may crawl
up surrounding structures and lay eggs in cracks and
crevices in these structures, which may also be used by
the larvae and nymphs [6, 9]. Dogs that are caged,
chained or kennelled may become particularly heavily
infested [8, 10] and all stages of development can sim-
ultaneously be present on the same dog [10, 11].
Ticks are vectors of many bacterial and protozoal dis-
eases in dogs. R. sanguineus (s.l.) has been confirmed or
implicated as the vector of the bacterial agents Ehrlichia
canis, Anaplasma platys, Rickettsia rickettsii, and Rick-
ettsia conorii and the protozoal organisms Babesia vogeli
and Hepatozoon canis [12]. The two most important
diseases in dogs caused by organisms transmitted by R.
sanguineus (s.l.) are canine monocytic ehrlichiosis
caused by E. canis and canine babesiosis caused by B.
vogeli [7]. Although data about the minimal time re-
quired for transmission of these pathogens are scarce, it
is accepted that the time required to transmit these two
diseases is very different. Transmission of protozoan
parasites like Babesia protozoa generally requires at
least 24 to 48 h after tick attachment, in order for their
sporoblasts to mature into sporozoites in the salivary
glands of the tick [13, 14]. In contrast, bacterial patho-
gens such as E. canis are transmitted by R. sanguineus
(s.l.) much more quickly - within a few hours after at-
tachment [15]. Consequently, in order to significantly
reduce the risk of tick-borne pathogens a product must
demonstrate a rapid onset of acaricidal and/or repellent
activity, preferably within a few hours.
The primary objective of the present study was to
evaluate the curative and preventive acaricidal efficacy
of a DPP combination against R. sanguineus (s.l.) mea-
sured at 2, 8, and 48 h after treatment and after weekly
re-infestation.
Methods
The study was a parallel group, blinded, randomized,
single centre, controlled efficacy study. The study was
conducted by an independent contract laboratory facility
in South Africa in accordance with the International
Cooperation on Harmonisation of Technical Require-
ments for Registration of Veterinary Medicinal Products
(VICH) guideline 9 entitled ‘Good Clinical Practice’. All
procedures were in compliance with South African
Animal Welfare Act Regulations ‘The care and use of
animals for scientific purposes’ and the protocol was
approved by the local animal ethics committee.
The 24 dogs enrolled in the investigation were mon-
grels of both sexes, older than six months, and weighed
between 10.4 and 22.8 kg. All dogs were dewormed prior
to the start of the study and were acclimatized to the
kennel environment for seven days before treatment.
The animals were housed individually for the duration
of the study in an indoor/outdoor run that conformed to
accepted animal welfare guidelines, and no physical con-
tact between dogs was possible. They were fed once a
day according to the food manufacturer’s recommenda-
tions, and water was available ad libitum.
The study design is summarized in Table 1. A laboratory-
bred strain (U.S. origin) of R. sanguineus (s.l.) was used
throughout the investigation. Ticks used for all infestations
were unfed, at least one week old and had a balanced sex
ratio (50 % female: 50 % male). Seven days before treatment
all the dogs were infested with 50 adult R. sanguineus.
Forty-eight hours after infestation the ticks were counted
and removed and the dogs were ranked within sex in de-
scending order of individual pre-treatment tick counts and
subsequently blocked into eight blocks of three animals
each. From each block, dogs were randomly allocated to
three groups of eight and the groups were coded to
blind the investigators performing the post-treatment
assessments. All dogs were infested on Day -2 and dogs
in Groups 2 and 3 were treated on Day 0 while dogs in
Group 1 served as untreated controls. In situ counts
were performed on dogs in Groups 1 and 3 on the day
of treatment and thereafter the dogs in Group 3 were
withdrawn from the study. The dogs in Group 3 were
included in the study because of the possibility of unin-
tentional manual removal of the DPP formulation while
the product was still drying during the in situ tick
counts performed at 2 h after administration. Dogs in
Groups 1 and 2 continued in the study with infestations
performed at weekly intervals from Day 7 through 42.
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Ticks on the dogs in Groups 1 and 2 were counted in
situ at 2 h and 8 h after each weekly re-infestation and
counted and removed 48 h after treatment on Day 0
and after each weekly re-infestation from Day 7 to Day
42 (Table 1). Ticks that were removed 48 h after treat-
ment or re-infestation were categorized according to
their attachment, engorgement and viability status at
the time of removal according to the parameters listed
in Table 2 [16].
Treatment was administered by parting the hair and
applying the appropriate volume (3.6 ml) of DPP directly
onto the skin in a continuous line from the base of the
tail along the middle of the back to between the shoul-
der blades, according to the label instructions. The time
at which treatment was administered to each animal and
the time at which it was infested with ticks were re-
corded. This was done to ensure that in situ counting of
ticks 2 h (± 5 min) or 8 h (± 30 min) after treatment or
re-infestation, and counting and removal of ticks 48 h (±
2 h) after treatment or re-infestation were accomplished
as close as possible to the specified target times. During
in situ counts, ticks were found by direct observation
following parting of the hair and by palpation. During
removal counts the same procedure was followed but
ticks were removed upon counting and the dogs were
also combed to ensure that all ticks had been counted
and removed.
The primary assessment criteria was the number of
ticks counted on the control and the treated groups of
dogs on the various assessment times and days, with ef-
ficacy calculations based on geometric (GM) and arith-
metic (AM) means. Geometric means were calculated
using the tick count data + 1, and 1 was subsequently
subtracted from the result to obtain a meaningful mean
value for each group. Efficacy of the DPP formulation
against adult R. sanguineus (s.l.) at 2, 8 and 48 h after
treatment or infestation was calculated as follows:
Efficacy %ð Þ ¼ 100  Mc– Mtð Þ = Mc
where:
Mc =Mean number of live ticks (categories 1, 2, 3 and
6) on dogs in the untreated control group (Group 1) at
a specific time point.
Mt =Mean number of live ticks (categories 1, 2, 3 and
6) on dogs in the treated groups (Groups 2 and 3) at a
specific time point.
Comparisons of tick counts between groups were con-
ducted using a one-way ANOVA with an administration
effect (P < 0.05). In addition, the groups were compared
by a non-parametric analysis using the Mann-Whitney
test on untransformed tick counts. Ticks in category 6
were included in the theoretical calculation because, if
found, these ticks would have succeeded in engorging
before they were killed. In this study, however, there
were no ticks classified as category 6.
Results
The GM number of ticks on the eight dogs in the untreated
control group varied between 24.0 and 31.5 in the counts
conducted 48 h after treatment or weekly re-infestation,
Table 1 Design of a study to determine the efficacy and speed of kill of DPP against adult R. sanguineus s.l
Day Procedure
-14 to -7 Acclimatization to kennel environment
-7 Infestation of all dogs with 50 adult ticks
-5 Tick counts and allocation of dogs to three groups of eight
-2 Infestation of dogs with 50 adult ticks
0 Topical application of DPP to dogs in Groups 2 and 3; in situ tick counts on dogs in Groups 1 and 3 at 2
and 8 h after treatment
1 Removal of ticks from dogs in Group 3 and withdrawal of this group of dogs from the study
2 Tick counts and tick removal on dogs in Groups 1 and 2
7, 14, 21, 28, 35, 42 Infestation of dogs in Groups 1 and 2 with 50 adult ticks; in situ tick counts on dogs in Groups 1
and 2 at 2 and 8 h after infestation
9, 16, 23, 30, 37, 44 Tick counts and tick removal on dogs in Groups 1 and 2, 48 h after infestation
Table 2 Status of adult R. sanguineus (s.l.) removed from dogs
48 h after treatment with DPP on Day 0 and after weekly re-
infestation from Day 7 to Day 42
Category Conditiona Attachment status
1 Live Unattached
2 Live Attached, unengorgedb
3 Live Attached, engorgedc
4 Dead Unattached
5 Dead Attached, unengorged
6 Dead Attached, engorged
aLive/Dead status determined by observation for movement after stimulus
with a probe or gentle CO2 exposure
bUnengorged = No filling of the alloscutum
cEngorged = obvious or conspicuous filling of the alloscutum
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demonstrating that an adequate level of infestation was
achieved in the control group. The efficacy of a single top-
ical application of DPP against adult R. sanguineus (s.l.) 2, 8
and 48 h after treatment or weekly re-infestation is summa-
rized in Fig. 1. Efficacy against a well established infestation
was not demonstrated at 2, 8 and 48 h after treatment in
this study. However, after weekly re-infestation on Days 7,
14, 21, 28, 35 and 42, the efficacy calculated with GM for
the 2 h counts was 68.9, 63.0, 72.2, 81.7, 65.8 and 51.8 %,
respectively (Table 3). By 8 h after infestation efficacy had
increased to 92.3, 92.2, 94.7, 98.1, 91.2 and 75.0 % on Days
7, 14, 21, 28, 35 and 42, respectively (Table 4). At 48 h after
infestation on Days 7, 14, 21, 28, 35 and 42 the calculated
efficacies were 93.5, 99.2, 99.1, 100.0, 90.4 and 87.8 %, re-
spectively (Table 5). There was a significant difference in all
counts conducted after Day 7 between the control and the
treated groups (P < 0.005).
Discussion
One of the most important aspects of a rapid speed of kill
for an acaricide is the prevention of tick-transmitted
diseases. In order to achieve this goal an acaricide should
prevent the attachment of ticks or rapidly kill them as
soon as they access the dog. Compliantly with previous
experiment [9], therapeutic efficacy against an existing
infestation was not demonstrated in this study. However,
high levels of preventive efficacy were quickly achieved
(Fig. 1; Table 3). By 2 h after infestation there were signifi-
cantly fewer ticks on treated dogs than on the controls.
The discrepancy between the therapeutic and preventive
efficacy can be explained by the time required for the
formulation to spread over the body of the dog and also
by the fact that permethrin has both a direct killing ef-
fect and an important repellent activity that prevents
ticks attaching to the dog and start feeding [2, 9].
0 7 14 21 28 35 42
2 hours 0.0% 68.9% 63.0% 72.2% 81.7% 65.8% 51.8%
8 hours 0.0% 92.3% 92.2% 94.7% 98.1% 91.2% 75.0%


















Fig. 1 Summary of calculated geometric mean efficacy of DPP against adult R. sanguineus (s.l.)
Table 3 Mean tick counts and percent efficacy of DPP at 2 hours after treatment or infestation against adult R. sanguineus (s.l.)
Day 0c 7 14 21 28 35 42
AMa tick counts control 28.1 39.1 38.1 37.6 38.3 41.0 38.8
AM tick counts treated 34.3 14.1 14.6 14.6 8.1 16.4 20.4
AM % efficacy 0 63.9d 61.6d 61.1d 78.8d 60.1d 47.4d
Test F(1,14) – 72.65 94.65 36.77 151.08 51.15 26.28
P-value – < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 0.0002
GMb tick counts control 27.7 38.8 37.8 37.5 37.9 40.8 38.4
GM tick counts treated 33.9 12.1 14.0 10.4 7.0 14.0 18.5
GM % efficacy 0 68.9d 63.0d 72.2d 81.7d 65.8d 51.8d
Test F(1,14) – 21.05 63.40 11.78 53.82 19.99 15.05
P-value – 0.0004 < 0.0001 0.004 < 0.0001 0.0005 0.0017
aAM arithmetic mean
bGM geometric mean
cCounts obtained from Group 3 dogs
dSignificant difference between treated and control group (P <0.05) based on ANOVA
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By Day 7 after treatment the active ingredients had
spread throughout the hair-coat and on the skin and
between 63 and 81.7 % of ticks were killed within 2 h
after being released onto dogs from Day 7 through Day
35, dropping to 51.8 % on Day 42 (it should be noted
that the DPP formulation is labelled for monthly re-
application). The rapid acaricidal efficacy observed at
2 h increased to > 90 % by 8 h after each infestation
from Day 7 through Day 35. The acaricidal efficacy
recorded 48 h after infestation was in concordance
with previous measurements performed against R.
sanguineus (s.l.) adult ticks with the same product for
1 month after treatment [9]. In the present experi-
ment, residual efficacy was assessed for 6 weeks and
was above 90 % (GM) for 5 weeks.
The earliest speed of kill data against R. sanguineus (s.l.)
reported after administration of a permethrin-based com-
bination product on dogs were recorded 3 h after weekly
infestation and efficacy varied from 69.9 to 88.1 % between
days 7 and 28 after treatment [17]. The acaricidal efficacy
at 2 h and strong level of prevention of re-infestation by
8 h is an important finding in that it has been demon-
strated that E. canis can be transmitted as early as 3 h
after exposure to infected R. sanguineus ticks [15]. Afoxo-
laner, a systemically active isoxazoline recommended for
monthly oral treatment, has been shown to have thera-
peutic acaricidal efficacy of 93 % by 12 h after treatment.
However, preventive efficacies were below 77 % at 12 h
against weekly infestations with I. ricinus from Day 7
through Day 28 [18] and between 0 and 14 % at 8 h
against weekly infestations with R. sanguineus from Day 7
through Day 35 after treatment [19]. Fluralaner, also a sys-
temically active isoxazoline recommended for oral admin-
istration once every 3 months, demonstrated a therapeutic
efficacy of 97.9 % against infestations with I. ricinus by 8 h
after treatment, and had preventive efficacy of 96.8 % by
8 h over the first 4 weeks after treatment. However, effi-
cacy declined to 83.5 and 45.8 % at weeks 8 and 12,
Table 4 Mean tick counts and percent efficacy of DPP at 8 hours after treatment or infestation against adult R. sanguineus (s.l.)
Day 0c 7 14 21 28 35 42
AMa tick counts control 25.0 34.3 27.6 35.3 33.9 29.5 37.6
AM tick counts treated 29.1 3.8 2.9 2.9 0.9 5.5 11.4
AM % efficacy 0.0 89.1d 89.6d 91.8d 97.4d 81.4d 69.8d
Test F(1,14) – 173.07 189.78 443.41 302.28 41.35 73.68
P-value – < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001
GMb tick counts control 24.7 33.9 27.3 35.1 33.5 28.7 37.3
GM tick counts treated 28.5 2.6 2.1 1.8 0.6 2.5 9.3
GM % efficacy 0.0 92.3d 92.2d 94.7d 98.1d 91.2d 75.0d
Test F(1,14) – 60.12 73.41 69.47 219.96 22.84 27.16
P-value – < 0.0001 < 0.0001 < 0.0001 < 0.0001 0.0003 0.0001
aAM arithmetic mean
bGM geometric mean
cCounts obtained from Group 3 dogs
dSignificant difference between treated and control group (p <0.05) based on ANOVA
Table 5 Mean tick counts and percent efficacy of DPP at 48 hours after treatment or infestation against adult R. sanguineus (s.l.)
Day 2 9 16 23 30 37 44
AMa tick counts control 27.9 26.4 30.8 31.9 30.8 31.3 24.5
AM tick counts treated 21.5 2.9 0.4 0.5 0.0 4.4 4.6
AM % efficacy 22.9 89.1c 98.8c 98.4c 100.0c 86.0c 81.1c
Test F(1,14) – 39.81 83.96 271.72 159.73 55.15 60.79
P-value – < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001
GMb tick counts control 27.0 24.9 29.7 31.5 30.1 30.0 24.0
GM tick counts treated 20.5 1.6 0.3 0.3 0.0 2.9 2.9
GM % efficacy 23.9 93.5c 99.2c 99.1c 100.0c 90.4c 87.8c
Test F(1,14) – 40.64 321.09 286.29 1, 964.66 34.60 26.80
P-value – < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 0.0001
aAM arithmetic mean
bGM geometric mean
cSignificant difference between treated and control group (P <0.05) based on ANOVA
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respectively [20]. In a comparative efficacy study of topical
DPP, oral fluralaner and oral afoxolaner that measured
their preventive acaricidal efficacy against R. sanguineus at
12 h, the topical formulation demonstrated 77–98 % effi-
cacy compared to 21–49 % for afoxolaner and 58–89 %
for fluralaner over a period of one month [21]. In another
study, in which acaricidal efficacy was measured at 3 h
after infestation with R. sanguineus, the efficacy of afoxola-
ner varied between zero and 26 % and of fluralaner be-
tween 13 and 53 %, and the tick counts of neither group
were significantly different from those of the negative con-
trol group at this time interval [22].
The rapid preventive acaricidal efficacy of the topical
formulation of DPP against new infestations of R. san-
guineus, could potentially reduce the likelihood of the
transmission of E. canis to dogs by infected ticks. More-
over, the sustained rapid preventive acaricidal efficacy
would also reduce the risk of dogs becoming infected
with other tick-borne diseases such as babesiosis associ-
ated with R. sanguineus. Regular monthly administration
of DPP would also prevent re-infestation by ticks and
prevent the development of local foci of tremendous
numbers of ticks so often associated with R. sanguineus
(s.l.). At localities where levels of infestation are particularly
severe, in addition to treating the dog with DPP, the envir-
onment should be thoroughly searched for ticks which can
then be eradicated by the application of a suitable acari-
cide formulated for this purpose. It is wise to remember
that there are always many more free-living ticks within
the dog’s environment than on the dog itself [6, 7].
Conclusion
This study demonstrated the high level of speed of kill of
DPP against new infestations of R. sanguineus (s.l.) ticks
on dogs. Topical treatment with the formulation reached
or exceeded 90 % efficacy within 8 h of infestation and a
significant number of newly acquired ticks were killed
within 2 h of infestation for up to 5 weeks after adminis-
tration. Monthly administration of this formulation can be
considered as a reliable tool for protection against ticks
and also likely for diseases they can transmit to dogs.
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